injection site tirzepatide Burning at Site: Causes and Solutions The 3 Most Common GLP-1

doi: 10.1111/dom.13107 33 JendleJGrunbergerGBlevinsTGiorginoFHietpasRTBotrosFT

Other possible causes include endometriosis, abdominal or pelvic surgery, pelvic inflammatory disease, other abdominal or pelvic infections, and previous tubal pregnancy (a dangerous condition in which the fertilized oocyte is implanted into the wall of a fallopian tube)

First Month of Semaglutide: only $299 1 - Save $200 Now

Treatments like intracavernous injections, topical alprostadil, or intraplaque verapamil are invasive

Antioxid Redox Signal 9 , 4989 (2007)

Certain factors may increase the likelihood of experiencing bloating on GLP-1 therapy, including: Pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS), functional dyspepsia, or small intestinal bacterial overgrowth (SIBO) Rapid dose escalation without adequate titration periods Dietary factors , particularly high intake of fermentable carbohydrates (FODMAPs), fatty foods, or carbonated beverages Concurrent medications that affect gastrointestinal motility Patients should be aware that GLP-1 receptor agonists have been associated with more serious gastrointestinal adverse effects, including pancreatitis (inflammation of the pancreas) and gallbladder disease